Case 21 — Reporting a suspected adverse reaction Method note for “Reporting a suspected adverse reaction”: use “Record the product, timing and a factu…

Clarification for “Recall notices: verify the product and jurisdiction”: the point beginning “Follow the official instructions and ask a pharmacist…” …

Case 35 — Recall notices: verify the product and jurisdiction · source wording exercise Summary draft for “Recall notices: verify the product and juri…

Case 46 — Expiry questions: why appearance cannot settle them · source wording exercise Correction note for “Expiry questions: why appearance cannot s…

Case 22 — Cold-chain questions: missing records are still missing It does not establish conditions throughout transport. Preserve the supplied informa…

Ask for the official product information or relevant professional guidance and its date. A person’s posting history does not establish clinical expert…

Method note for “Conflicting advice: identify the original source”: use “Ask for the official product information or relevant…” as a row heading in a …

Case 2 — Source-review index: unresolved, documented and corrected Use clear evidence-status labels and dates, and link to the underlying records. Avo…

Case 42 — Packaging evidence: a mismatch is a question, not an authenticity verdict · source wording exercise Reader check for “Packaging evidence: a …

Method note for “Delivery feedback is not a medicine-quality assessment”: use “Describe it as a delivery observation with…” as a row heading in a prop…

Identify the specific statement, explain the evidence gap and link authoritative information where available. Preserve a dated correction and avoid su…

Case 32 — Review chronology: order date is different from delivery evidence · source wording exercise Limit of the answer in “Review chronology: order…

Case 34 — Reporting a suspected adverse reaction · source wording exercise Limit of the answer in “Reporting a suspected adverse reaction”: “Seek appr…

Look for manufacturer or regulator documentation and record the date and market it covers. Treat an unsupported explanation as unresolved, not as proo…

Case 22 — Redacting a review: which details should stay private? Batch and product information may be relevant to a pharmacist or regulator. Decide wh…